SEOM clinical guidelines in metastatic breast cancer 2015

Metastatic breast cancer is essentially an incurable disease. However, recent advances have resulted in a significant improvement of overall survival. The SEOM guidelines are intended to make evidence-based recommendations on how to manage patients with metastatic breast cancer to achieve the best p...

Descripción completa

Detalles Bibliográficos
Autores principales: Gavilá, J., Lopez-Tarruella, S., Saura, C., Muñoz, M., Oliveira, M., De la Cruz-Merino, L., Morales, S., Alvarez, I., Virizuela, J. A., Martin, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2015
Materias:
Clinical Guides in Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689775/
https://www.ncbi.nlm.nih.gov/pubmed/26683474
http://dx.doi.org/10.1007/s12094-015-1476-7
_version_ 1782406889620897792
author Gavilá, J.
Lopez-Tarruella, S.
Saura, C.
Muñoz, M.
Oliveira, M.
De la Cruz-Merino, L.
Morales, S.
Alvarez, I.
Virizuela, J. A.
Martin, M.
author_facet Gavilá, J.
Lopez-Tarruella, S.
Saura, C.
Muñoz, M.
Oliveira, M.
De la Cruz-Merino, L.
Morales, S.
Alvarez, I.
Virizuela, J. A.
Martin, M.
author_sort Gavilá, J.
collection PubMed
description Metastatic breast cancer is essentially an incurable disease. However, recent advances have resulted in a significant improvement of overall survival. The SEOM guidelines are intended to make evidence-based recommendations on how to manage patients with metastatic breast cancer to achieve the best patient outcomes based on a rational use of the currently available therapies. To assign a level of certainty and a grade of recommendation the United States Preventive Services Task Force guidelines methodology was selected as reference.
format Online
Article
Text
id pubmed-4689775
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Springer Milan
record_format MEDLINE/PubMed
spelling pubmed-46897752015-12-31 SEOM clinical guidelines in metastatic breast cancer 2015 Gavilá, J. Lopez-Tarruella, S. Saura, C. Muñoz, M. Oliveira, M. De la Cruz-Merino, L. Morales, S. Alvarez, I. Virizuela, J. A. Martin, M. Clin Transl Oncol Clinical Guides in Oncology Metastatic breast cancer is essentially an incurable disease. However, recent advances have resulted in a significant improvement of overall survival. The SEOM guidelines are intended to make evidence-based recommendations on how to manage patients with metastatic breast cancer to achieve the best patient outcomes based on a rational use of the currently available therapies. To assign a level of certainty and a grade of recommendation the United States Preventive Services Task Force guidelines methodology was selected as reference. Springer Milan 2015-12-18 2015 /pmc/articles/PMC4689775/ /pubmed/26683474 http://dx.doi.org/10.1007/s12094-015-1476-7 Text en © The Author(s) 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Clinical Guides in Oncology
Gavilá, J.
Lopez-Tarruella, S.
Saura, C.
Muñoz, M.
Oliveira, M.
De la Cruz-Merino, L.
Morales, S.
Alvarez, I.
Virizuela, J. A.
Martin, M.
SEOM clinical guidelines in metastatic breast cancer 2015
title SEOM clinical guidelines in metastatic breast cancer 2015
title_full SEOM clinical guidelines in metastatic breast cancer 2015
title_fullStr SEOM clinical guidelines in metastatic breast cancer 2015
title_full_unstemmed SEOM clinical guidelines in metastatic breast cancer 2015
title_short SEOM clinical guidelines in metastatic breast cancer 2015
title_sort seom clinical guidelines in metastatic breast cancer 2015
topic Clinical Guides in Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689775/
https://www.ncbi.nlm.nih.gov/pubmed/26683474
http://dx.doi.org/10.1007/s12094-015-1476-7
work_keys_str_mv AT gavilaj seomclinicalguidelinesinmetastaticbreastcancer2015
AT lopeztarruellas seomclinicalguidelinesinmetastaticbreastcancer2015
AT saurac seomclinicalguidelinesinmetastaticbreastcancer2015
AT munozm seomclinicalguidelinesinmetastaticbreastcancer2015
AT oliveiram seomclinicalguidelinesinmetastaticbreastcancer2015
AT delacruzmerinol seomclinicalguidelinesinmetastaticbreastcancer2015
AT moraless seomclinicalguidelinesinmetastaticbreastcancer2015
AT alvarezi seomclinicalguidelinesinmetastaticbreastcancer2015
AT virizuelaja seomclinicalguidelinesinmetastaticbreastcancer2015
AT martinm seomclinicalguidelinesinmetastaticbreastcancer2015

Ejemplares similares